William T. Berger, Ph.D.
Affiliations: | 2013 | Chemistry | Stony Brook University, Stony Brook, NY, United States |
Google:
"William Berger"Mean distance: 2745.72
Parents
Sign in to add mentor| Iwao Ojima | grad student | 2013 | SUNY Stony Brook | |
| (Drug discovery through combination of computational screening and design, chemical synthesis and biological evaluations.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Teng YH, Berger WT, Nesbitt NM, et al. (2015) Computer-aided identification, synthesis, and biological evaluation of novel inhibitors for botulinum neurotoxin serotype A. Bioorganic & Medicinal Chemistry. 23: 5489-95 |
| Elmes MW, Kaczocha M, Berger WT, et al. (2015) Fatty acid-binding proteins (FABPs) are intracellular carriers for Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD). The Journal of Biological Chemistry. 290: 8711-21 |
| Kaczocha M, Rebecchi MJ, Ralph BP, et al. (2014) Inhibition of fatty acid binding proteins elevates brain anandamide levels and produces analgesia. Plos One. 9: e94200 |
| Berger WT, Ralph BP, Kaczocha M, et al. (2013) High throughput fluorescence displacement assay with NBD-stearate. Plos One |
| Berger WT, Ralph BP, Kaczocha M, et al. (2013) Scheme demonstrating anandamide inactivation and FABP drug target. Plos One |
| Berger WT, Ralph BP, Kaczocha M, et al. (2012) Targeting fatty acid binding protein (FABP) anandamide transporters - a novel strategy for development of anti-inflammatory and anti-nociceptive drugs. Plos One. 7: e50968 |
| Ojima I, Zuniga ES, Berger WT, et al. (2012) Tumor-targeting drug delivery of new-generation taxoids. Future Medicinal Chemistry. 4: 33-50 |
| Kumar K, Awasthi D, Berger WT, et al. (2010) Discovery of anti-TB agents that target the cell-division protein FtsZ. Future Medicinal Chemistry. 2: 1305-23 |